Results
|
8081.
|
|
|
8082.
|
|
|
8083.
|
|
|
8084.
|
|
|
8085.
|
|
|
8086.
|
|
|
8087.
|
|
|
8088.
|
|
|
8089.
|
|
|
8090.
|
|
|
8091.
|
|
|
8092.
|
|
|
8093.
|
|
|
8094.
|
Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations. [electronic resource] by
- Huret, J L
- Brizard, A
- Slater, R
- Charrin, C
- Bertheas, M F
- Guilhot, F
- Hählen, K
- Kroes, W
- van Leeuwen, E
- Schoot, E V
Producer: 19930301
In:
Leukemia vol. 7
Availability: No items available.
|
|
8095.
|
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group. [electronic resource] by
- Carella, A M
- Carlier, P
- Pungolino, E
- Resegotti, L
- Liso, V
- Stasi, R
- Montillo, M
- Iacopino, P
- Mirto, S
- Pagano, L
Producer: 19930301
In:
Leukemia vol. 7
Availability: No items available.
|
|
8096.
|
|
|
8097.
|
|
|
8098.
|
|
|
8099.
|
|
|
8100.
|
|